Download PDF
Semin Thromb Hemost 1997; 23(6): 543-545
DOI: 10.1055/s-2007-996133
Copyright © 1997 by Thieme Medical Publishers, Inc.

Hypercoagulability in Heart Failure

Syed M. Jafri
  • From the Division of Cardiovascular Medicine, Henry Ford Hospital, Detroit, Michigan.
Further Information

Publication History

Publication Date:
08 February 2008 (online)

  PDF Download  Permissions and Reprints

Abstract

Thromboembolism is an important complication in patients with heart failure. A variety of factors associated with heart failure predispose to thrombosis. These include vascular pathology, increased coagulability, and impaired flow. The focus of this review is to summarize data on platelet function and coagulation indices in heart failure. Several studies have shown that patients with heart failure have increased plasma concentrations of β-thromboglobulin, a marker of platelet activation. Increased plasma concentrations of fibrinopeptide A and thrombin activation have also been demonstrated. In addition, plasma concentrations of endothelial procoagulants, von Willebrand factor, fibrinolytic products, and Ddimer are also increased during heart failure. If platelet activation and hypercoagulability are a surrogate for clinical events, treatment with antiplatelet or anticoagulant therapy can potentially reduce thromboembolism and mortality in heart failure.

Keywords:

Heart failure - hypercoagulability - thromboembolism - platelet function

      >